placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan — Competitive Intelligence Brief

placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan (placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combination cold and cough remedy. Area: Respiratory/Cold and Cough.

marketed Combination cold and cough remedy H1 receptor (diphenhydramine); alpha-1 adrenergic receptor (phenylephrine); sigma-1 receptor and NMDA receptor (dextromethorphan) Respiratory/Cold and Cough Small molecule

Target snapshot

placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan (placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan) — Montefiore Medical Center. This combination product uses an antihistamine, decongestant, and cough suppressant to reduce cold and cough symptoms through multiple pathways.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan TARGET	placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan	Montefiore Medical Center	marketed	Combination cold and cough remedy	H1 receptor (diphenhydramine); alpha-1 adrenergic receptor (phenylephrine); sigma-1 receptor and NMDA receptor (dextromethorphan)
dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa	dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa	Montefiore Medical Center	marketed	Combination cold and cough remedy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combination cold and cough remedy class)

1. Montefiore Medical Center · 2 drugs in this class